Gut microbiota in early pediatric multiple sclerosis: a case-control study/Experiment 2/Signature 1
From BugSigDB
Reviewed Marked as Reviewed by Atrayees on 2023-6-30
Source: Figure 2b
Description: Difference between multiple sclerosis and controls influenced by the immunomodulatory drug IMD exposure status of cases
Abundance in Group 1: increased abundance in IMD exposure multiple sclerosis cases
| NCBI | Quality Control | Links |
|---|---|---|
| Actinomycetota |
Revision editor(s): WikiWorks
